7
Total investments
1
Early stage
3
Mid stage
0
Late stage
17y
Years active
Portfolio
7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Apr 2021
We aspire to build transformative precision medicines for patients with cancer and other serious conditions.
Board Member
May 2019
Atrial Fibrillation (AF) is the most frequent arrhythmic disorder of the heart. At Ablacon, we leverage our expertise in electrophysiology, computer vision and deep learning to build a real-time high-precision AI-based diagnosis system.
We are an international team based in Lausanne (CH), Denver, CO (US) and Munich (DE) with a partner clinic in Hamburg (DE).
If you are looking for the next big challenge, a wonderful team and a purpose that literally saves lives, you might want to consider joining us.
Board Member
May 2019
Cortica is a leading provider of ABA and other therapies for children with autism, with services available in-center, in-home, and via telehealth. Cortica’s personalized, whole-child approach integrates diagnostic services, medical services for autism’s co-occurring conditions, developmental therapies including occupational therapy and speech-language therapy, and individual and family counseling, all under one roof. For more information, please visit corticacare.com.
S
Board Member
Apr 2015
Spirox is committed to improving the quality of life for patients suffering from nasal obstruction, a condition that affects more than 20 million individuals in the United States. The Menlo Park-based company’s first product—the LATERA absorbable nasal implant—is designed to address one of the most common, yet undertreated, causes of nasal obstruction today, nasal valve collapse (NVC). For more information, please visit www.spiroxmed.com. LATERA is available in the U.S. only. Spirox and LATERA and its logos are trademarks of Spirox, Inc.
Board Observer
Jul 2013
Loxo@Lilly aims to create medicines that make life better for all those affected
by cancer around the world. Bringing together the focus and spirit of a biotech
with the scale, resources, and heritage of Lilly, our team is focused on rapidly
delivering impactful new medicines for people with cancer. Our approach centers on creating oncology medicines that unequivocally show early signs of clinical activity and will matter to patients.
Loxo@Lilly is a global organization with team members in Boulder, Colorado; Indianapolis, Indiana; New York City, New York; San Diego, California; South San Francisco, California; Stamford, Connecticut; and Madrid, Spain.
Board Member
Oct 2009
Asensus Surgical is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking the Clinical Intelligence to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare.
Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.Senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: https://www.senhance.com/indications.
Experience · 9 entries
All (9)
Investments (7)
Board (7)
2022
2021
Board Member
Apr 2021
We aspire to build transformative precision medicines for patients with cancer and other serious conditions.
2020
Chief Medical Officer, Managing Director
2020
Ajax Health deploys capital and leverages operational experience to accelerate healthcare innovation across medical devices, digital health, healthcare services and biotechnology. We partner with entrepreneurs across all stages of a company's lifecycle and leverage deep domain expertise to support business strategy, clinical & regulatory, R&D and M&A.
2019
Board Member
May 2019
Atrial Fibrillation (AF) is the most frequent arrhythmic disorder of the heart. At Ablacon, we leverage our expertise in electrophysiology, computer vision and deep learning to build a real-time high-precision AI-based diagnosis system.
We are an international team based in Lausanne (CH), Denver, CO (US) and Munich (DE) with a partner clinic in Hamburg (DE).
If you are looking for the next big challenge, a wonderful team and a purpose that literally saves lives, you might want to consider joining us.
Board Member
May 2019
Cortica is a leading provider of ABA and other therapies for children with autism, with services available in-center, in-home, and via telehealth. Cortica’s personalized, whole-child approach integrates diagnostic services, medical services for autism’s co-occurring conditions, developmental therapies including occupational therapy and speech-language therapy, and individual and family counseling, all under one roof. For more information, please visit corticacare.com.
Show all 9 entries ↓
Investment activity
2009–2022 · 7 investments
Recent (last 2 years)Earlier
